Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

JAK inhibitors show promise for treating various skin diseases.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Stem-cell therapy shows promise for skin conditions but needs more research.

Hypothyroidism may cause certain types of hair loss.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.